Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
Appointed director
AIM ImmunoTech Inc. (HEB) Create: Alert

All | News | Filings
Date FiledTypeDescription
09/29/2023 8-K Quarterly results
08/23/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "VIA E-MAIL AND FEDEX",
"AIM ImmunoTech Rejects Director Nomination Notice from Activist Group Due to Numerous Material Defects, Omissions and False and Misleading Statements"
08/15/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
07/10/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
04/19/2023 8-K Quarterly results
03/30/2023 8-K Quarterly results
03/16/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
03/13/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
03/08/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
03/06/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "AIM ImmunoTech Issues Letter to Stockholders"
02/24/2023 8-K Regulation FD Disclosure  Interactive Data
02/10/2023 8-K Quarterly results
02/06/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
01/17/2023 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
11/09/2022 8-K Quarterly results
09/09/2022 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
07/18/2022 8-K Quarterly results
06/21/2022 8-K Quarterly results
06/17/2022 8-K Quarterly results
04/12/2022 8-K Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits  Inte...
Docs: "Prepared for:"
03/28/2022 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
03/16/2022 8-K Other Events, Financial Statements and Exhibits  Interactive Data
03/07/2022 8-K Quarterly results
03/03/2022 8-K Quarterly results
01/27/2022 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
01/26/2022 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
01/24/2022 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
12/09/2021 8-K Quarterly results
10/07/2021 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
10/06/2021 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "AIM ImmunoTech Publishes Phase 1 Clinical Study Data Supporting the Safety of Ampligen as an Intranasal Therapy"
09/30/2021 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "AIM ImmunoTech Announces Clinical Trial Agreement for a Phase 2a Human Challenge Trial of Ampligen as a Potential Intranasal Prophylaxis Against Respiratory Viruses"
09/21/2021 8-K Quarterly results
09/17/2021 8-K Quarterly results
07/14/2021 8-K Investor presentation
Docs: "Company Presentation dated July 2021"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy